Milestone Pharmaceuticals Inc. — All Filings
395 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | — | 0001415889-24-019666 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | — | 0001415889-24-019668 | Jul 17, 2024 | Jul 15, 2024 |
| SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-24-001575 | Jul 16, 2024 | — |
| ARS | ARS | 0001104659-24-079882 | Jul 15, 2024 | Dec 31, 2023 |
| DEFA14A | DEFA14A | 0001104659-24-079880 | Jul 15, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-079854 | Jul 15, 2024 | Jul 14, 2024 |
| DEF 14A | DEF 14A | 0001104659-24-079878 | Jul 15, 2024 | Aug 28, 2024 |
| DEFA14A | DEFA14A | 0001104659-24-079881 | Jul 15, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-065806 | May 29, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-007860 | May 13, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001104659-24-060221 | May 13, 2024 | — |
| 10-K/A | FORM 10-K/A | 0001104659-24-054157 | Apr 29, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001104659-24-044767 | Apr 8, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-040008 | Mar 28, 2024 | — |
| 10-K | 10-K | 0001558370-24-003666 | Mar 21, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001104659-24-036941 | Mar 21, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-030267 | Mar 4, 2024 | Feb 28, 2024 |
| 424B5 | 424B5 | 0001104659-24-030025 | Mar 1, 2024 | — |
| 424B5 | 424B5 | 0001104659-24-028800 | Feb 28, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-027262 | Feb 26, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024237 | Feb 14, 2024 | — |
| SC 13G/A | MILESTONE PHARMACEUTICALS INC. | 0000902664-24-001547 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001319244-24-000017 | Jan 29, 2024 | — |
| SC 13G/A | — | 0001086364-24-002358 | Jan 24, 2024 | — |
| 8-K | FORM 8-K | 0001104659-23-128988 | Dec 26, 2023 | — |
| 10-Q | 10-Q | 0001558370-23-018665 | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | FORM 8-K | 0001104659-23-116598 | Nov 13, 2023 | Nov 11, 2023 |
| 8-K | FORM 8-K | 0001104659-23-116646 | Nov 13, 2023 | — |
| SC 13D | THE SCHEDULE 13D | 0000921895-23-002543 | Nov 9, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-115048 | Nov 7, 2023 | — |
| 8-K | FORM 8-K | 0001104659-23-111088 | Oct 24, 2023 | — |
| 10-Q | 10-Q | 0001558370-23-014399 | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | FORM 8-K | 0001104659-23-089566 | Aug 10, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035844 | Jun 9, 2023 | Jun 7, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035841 | Jun 9, 2023 | Jun 7, 2023 |
| 8-K | FORM 8-K | 0001104659-23-069992 | Jun 9, 2023 | Jun 7, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035825 | Jun 9, 2023 | Jun 7, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035836 | Jun 9, 2023 | Jun 7, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035838 | Jun 9, 2023 | Jun 7, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-035843 | Jun 9, 2023 | Jun 7, 2023 |
| 10-K/A | 10-K/A | 0001104659-23-066205 | May 31, 2023 | Dec 31, 2022 |
| 424B5 | 424B5 | 0001104659-23-066694 | May 31, 2023 | — |
| EFFECT | — | 9999999995-23-001559 | May 26, 2023 | — |
| CORRESP | — | 0001104659-23-063914 | May 24, 2023 | — |
| UPLOAD | — | 0000000000-23-005311 | May 18, 2023 | — |
| S-3 | S-3 | 0001104659-23-060930 | May 15, 2023 | — |
| 10-Q | 10-Q | 0001558370-23-009254 | May 11, 2023 | Mar 31, 2023 |
| 8-K | FORM 8-K | 0001104659-23-058749 | May 11, 2023 | — |
| DEF 14A | DEF 14A | 0001104659-23-052993 | Apr 28, 2023 | Jun 7, 2023 |
| DEFA14A | DEF 14A | 0001104659-23-053003 | Apr 28, 2023 | — |